Seguir
Ajay Major, MD, MBA
Ajay Major, MD, MBA
University of Colorado School of Medicine
Dirección de correo verificada de cuanschutz.edu - Página principal
Título
Citado por
Citado por
Año
Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: Real-world outcomes from 21 US academic institutions
VM Orellana-Noia, DR Reed, AA McCook, JM Sen, CM Barlow, ...
Blood 139 (3), 413-423, 2022
872022
PD-1 blockade in mediastinal gray-zone lymphoma
C Melani, A Major, J Schowinsky, M Roschewski, S Pittaluga, ES Jaffe, ...
The New England Journal of Medicine 377 (1), 89, 2017
712017
Documenting social media engagement as scholarship: A new model for assessing academic accomplishment for the health professions
KD Acquaviva, J Mugele, N Abadilla, T Adamson, SL Bernstein, ...
Journal of Medical Internet Research 22 (12), e25070, 2020
512020
To bully and be bullied: Harassment and mistreatment in medical education
A Major
AMA Journal of Ethics 16 (3), 155-160, 2014
502014
Carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone as maintenance therapy after autologous stem-cell transplantation in patients with multiple myeloma (ATLAS …
D Dytfeld, T Wróbel, K Jamroziak, T Kubicki, P Robak, A Walter-Croneck, ...
The Lancet Oncology 24 (2), 139-150, 2023
452023
Management of hemophagocytic lymphohistiocytosis (HLH) associated with chimeric antigen receptor T-cell (CAR-T) therapy using anti-cytokine therapy: an illustrative case and …
A Major, J Collins, C Craney, AK Heitman, E Bauer, E Zerante, W Stock, ...
Leukemia & Lymphoma, 1-7, 2021
412021
Using big data in pediatric oncology: Current applications and future directions
A Major, SM Cox, SL Volchenboum
Seminars in Oncology 47 (1), 56-64, 2020
372020
Persistence of Ad26.COV2.S‐associated vaccine‐induced immune thrombotic thrombocytopenia (VITT) and specific detection of VITT antibodies
AJ Kanack, B Singh, G George, K Gundabolu, SA Koepsell, ...
American Journal of Hematology, 2022
362022
DA-R-EPOCH vs R-CHOP in DLBCL: how do we choose?
A Major, SM Smith
Clinical advances in hematology & oncology: H&O 19 (11), 698, 2021
342021
Phase I/II clinical trial of temsirolimus and lenalidomide in patients with relapsed and refractory lymphomas
A Major, J Kline, TG Karrison, PAS Fishkin, AS Kimball, AM Petrich, ...
Haematologica, 2022
282022
Elotuzumab and weekly carfilzomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma without transplant intent: A phase 2 measurable residual …
BA Derman, A Kansagra, J Zonder, AT Stefka, DL Grinblatt, LD Anderson, ...
JAMA Oncology, 2022
272022
Dynamic frailty risk assessment among older adults with multiple myeloma: A population-based cohort study
H Mian, TM Wildes, R Vij, MJ Pianko, A Major, MA Fiala
Blood cancer journal 13 (1), 76, 2023
262023
Applications of artificial intelligence in pediatric oncology: A systematic review
S Ramesh, S Chokkara, T Shen, A Major, SL Volchenboum, ...
JCO Clinical Cancer Informatics 5, 1208-1219, 2021
262021
Efficacy of checkpoint inhibition after CAR-T failure in aggressive B-cell lymphomas: Outcomes from 15 US institutions
A Major, J Yu, N Shukla, Y Che, TG Karrison, R Treitman, MK Kamdar, ...
Blood advances 7 (16), 4528-4538, 2023
212023
Refractory vaccine-induced immune thrombotic thrombocytopenia (VITT) managed with delayed therapeutic plasma exchange (TPE)
A Major, T Carll, CW Chan, C Christenson, F Aldarweesh, GD Wool, ...
Journal of Clinical Apheresis, 2021
212021
Risk and subtypes of secondary primary malignancies in diffuse large B‐cell lymphoma survivors change over time based on stage at diagnosis
A Major, DE Smith, D Ghosh, R Rabinovitch, M Kamdar
Cancer 126 (1), 189-201, 2020
212020
Older patients with primary central nervous system lymphoma: Survival and prognostication across 20 US cancer centers
KA David, S Sundaram, SH Kim, R Vaca, Y Lin, S Singer, MK Malecek, ...
American Journal of Hematology, 2023
182023
Removing barriers: A confidential opt-out mental health pilot program for internal medicine interns
A Major, JG Williams, WC McGuire, E Floyd, K Chacko
Academic Medicine: Journal of the Association of American Medical Colleges, 2021
172021
CNS prophylaxis during front-line therapy in aggressive non-Hodgkin lymphomas: Real-world outcomes and practice patterns from 19 US academic institutions
VM Orellana-Noia, DR Reed, JM Sen, C Barlow, MK Malecek, ...
Blood 136 (Supplement 1), 27-28, 2020
162020
Inferior outcomes and treatment disparities in elderly patients with classical Hodgkin lymphoma: A National Cancer Data Base analysis
A Major, MW Jackson, DE Smith, M Kamdar, R Rabinovitch
Leukemia & lymphoma 60 (5), 1234-1243, 2019
152019
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20